Abstract

Traditional She medicine is part of China’s cultural heritage and has become remarkably popular worldwide. The Shi-Liang tea is made from the processed leaves of Chimonanthus salicifolius S. Y. Hu and Chimonanthus zhejiangensis M. C. Liu. To ensure the safety and efficacy of Shi-Liang tea, we used DNA barcoding based on the internal transcribed spacer 2 (ITS2) of nuclear ribosomal DNA to distinguish the original plant sources of Shi-Liang tea from closely related species. All 71 ITS2 sequences were aligned by Clustal-W, and genetic distances were computed using MEGA 6.0 according to the Kimura 2-parameter model. The results indicated that the sequence lengths of ITS2 regions of the original plants of Shi-Liang tea and closely related species ranged from 256 bp to 260 bp. Interspecific genetic distances ranged from 0 to 0.078. The neighbor-joining (NJ) tree showed that the original plants of Shi-Liang tea species can be easily differentiated from closely related species. Distinct molecular differences were found between the secondary structures of ITS2 sequences from Shi-Liang tea and closely related species. The results in the present investigation suggested that the ITS2 could be an effective DNA marker to identify the original plants of Shi-Liang tea and their closely related species. These DNA barcodes can greatly benefit the supervision of the commercial circulation of She medicine.

Highlights

  • Traditional She medicine is an important part of folk medicine with a long history

  • The internal transcribed spacer 2 (ITS2) sequences of C. salicifolius ranged from 256 bp to 258 bp, while those of C. zhejiangensis were 256 bp in length

  • The results showed that the ITS2 barcoding regions could be amplified with sufficient discrimination as a candidate marker to identify Shi-Liang tea

Read more

Summary

Introduction

Traditional She medicine is an important part of folk medicine with a long history. The She medicine has attracted much attention from the Han and She ethnic groups in Southeastern China, especially in the Zhejiang and Fujian provinces. This traditional Chinese medicine was gradually developed to prevent and treat diseases under particular historical conditions and special geographical environments when the She minority group struggled with diseases to survive and reproduce [1,2,3].

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call